NO20073176L - Nye medikamenter for behandling av luftveissykdommer - Google Patents
Nye medikamenter for behandling av luftveissykdommerInfo
- Publication number
- NO20073176L NO20073176L NO20073176A NO20073176A NO20073176L NO 20073176 L NO20073176 L NO 20073176L NO 20073176 A NO20073176 A NO 20073176A NO 20073176 A NO20073176 A NO 20073176A NO 20073176 L NO20073176 L NO 20073176L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- respiratory diseases
- new drugs
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Anvendelsen av forbindelser med den generelle Formel 1, hvor restene R1, R2 og R3 kan ha de betydninger som er nevnt i kravene og i beskrivelsen, for fremstilling av et medikament til behandling av luftveissykdommer, samt nye forbindelser med Formel 1, fremgangsmåter for fremstilling av disse og farmasøytiske formuleringer som inneholder disse, beskrives.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005008921A DE102005008921A1 (de) | 2005-02-24 | 2005-02-24 | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
PCT/EP2006/060033 WO2006089859A1 (de) | 2005-02-24 | 2006-02-16 | Neue arzneimittel zur behandlung von atemwegserkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073176L true NO20073176L (no) | 2007-09-17 |
Family
ID=36179764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073176A NO20073176L (no) | 2005-02-24 | 2007-06-22 | Nye medikamenter for behandling av luftveissykdommer |
Country Status (26)
Country | Link |
---|---|
US (3) | US20060189605A1 (no) |
EP (1) | EP1856070B1 (no) |
JP (1) | JP4950075B2 (no) |
KR (1) | KR20070110386A (no) |
CN (1) | CN101128444A (no) |
AR (1) | AR055562A1 (no) |
AT (1) | ATE517877T1 (no) |
AU (1) | AU2006218010B2 (no) |
BR (1) | BRPI0607258A2 (no) |
CA (1) | CA2598914A1 (no) |
DE (1) | DE102005008921A1 (no) |
DK (1) | DK1856070T3 (no) |
EA (1) | EA012439B1 (no) |
ES (1) | ES2370653T3 (no) |
IL (1) | IL185444A0 (no) |
MX (1) | MX2007010363A (no) |
MY (1) | MY146802A (no) |
NO (1) | NO20073176L (no) |
NZ (1) | NZ561743A (no) |
PE (1) | PE20061097A1 (no) |
PL (1) | PL1856070T3 (no) |
TW (1) | TWI369988B (no) |
UA (1) | UA90504C2 (no) |
UY (1) | UY29394A1 (no) |
WO (1) | WO2006089859A1 (no) |
ZA (1) | ZA200704727B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
US7423146B2 (en) | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
PE20080610A1 (es) * | 2006-08-22 | 2008-07-15 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos |
UY30552A1 (es) * | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones |
CA2661481A1 (en) * | 2006-08-22 | 2008-02-28 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation containing enantiomerically pure beta-agonists |
EP2093219A1 (de) * | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
GB201217330D0 (en) * | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
HUE045409T2 (hu) | 2014-12-24 | 2019-12-30 | Kither Biotech S R L | Új PI3K gamma inhibitor peptid légzõszervi betegségek kezelésére |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3026534A1 (de) * | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
DE3609152A1 (de) * | 1986-03-19 | 1987-09-24 | Bayer Ag | Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens |
PL1613315T3 (pl) * | 2003-04-04 | 2009-07-31 | Novartis Ag | Pochodne chinolino-2-onu do leczenia chorób dróg oddechowych |
DE102004003428A1 (de) * | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
UY30552A1 (es) * | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones |
-
2005
- 2005-02-24 DE DE102005008921A patent/DE102005008921A1/de not_active Withdrawn
-
2006
- 2006-02-16 ES ES06708325T patent/ES2370653T3/es active Active
- 2006-02-16 KR KR1020077021896A patent/KR20070110386A/ko not_active Application Discontinuation
- 2006-02-16 AT AT06708325T patent/ATE517877T1/de active
- 2006-02-16 WO PCT/EP2006/060033 patent/WO2006089859A1/de active Application Filing
- 2006-02-16 AU AU2006218010A patent/AU2006218010B2/en not_active Expired - Fee Related
- 2006-02-16 MX MX2007010363A patent/MX2007010363A/es active IP Right Grant
- 2006-02-16 EP EP06708325A patent/EP1856070B1/de active Active
- 2006-02-16 NZ NZ561743A patent/NZ561743A/en not_active IP Right Cessation
- 2006-02-16 DK DK06708325.3T patent/DK1856070T3/da active
- 2006-02-16 CN CNA2006800060256A patent/CN101128444A/zh active Pending
- 2006-02-16 CA CA002598914A patent/CA2598914A1/en not_active Abandoned
- 2006-02-16 BR BRPI0607258-5A patent/BRPI0607258A2/pt not_active IP Right Cessation
- 2006-02-16 EA EA200701615A patent/EA012439B1/ru not_active IP Right Cessation
- 2006-02-16 PL PL06708325T patent/PL1856070T3/pl unknown
- 2006-02-16 UA UAA200710494A patent/UA90504C2/ru unknown
- 2006-02-16 JP JP2007556591A patent/JP4950075B2/ja active Active
- 2006-02-22 PE PE2006000215A patent/PE20061097A1/es not_active Application Discontinuation
- 2006-02-22 MY MYPI20060756A patent/MY146802A/en unknown
- 2006-02-23 TW TW095106149A patent/TWI369988B/zh not_active IP Right Cessation
- 2006-02-23 US US11/276,307 patent/US20060189605A1/en not_active Abandoned
- 2006-02-24 UY UY29394A patent/UY29394A1/es not_active Application Discontinuation
- 2006-02-24 AR ARP060100674A patent/AR055562A1/es unknown
-
2007
- 2007-06-14 ZA ZA200704727A patent/ZA200704727B/xx unknown
- 2007-06-22 NO NO20073176A patent/NO20073176L/no not_active Application Discontinuation
- 2007-08-22 IL IL185444A patent/IL185444A0/en unknown
-
2008
- 2008-12-18 US US12/338,333 patent/US20090105236A1/en not_active Abandoned
-
2010
- 2010-11-05 US US12/940,492 patent/US20110053926A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL185444A0 (en) | 2008-01-06 |
EA012439B1 (ru) | 2009-10-30 |
BRPI0607258A2 (pt) | 2009-08-25 |
MY146802A (en) | 2012-09-28 |
PE20061097A1 (es) | 2006-11-14 |
AR055562A1 (es) | 2007-08-22 |
TWI369988B (en) | 2012-08-11 |
JP4950075B2 (ja) | 2012-06-13 |
US20110053926A1 (en) | 2011-03-03 |
ZA200704727B (en) | 2008-09-25 |
KR20070110386A (ko) | 2007-11-16 |
ATE517877T1 (de) | 2011-08-15 |
EP1856070B1 (de) | 2011-07-27 |
CA2598914A1 (en) | 2006-08-31 |
US20060189605A1 (en) | 2006-08-24 |
ES2370653T3 (es) | 2011-12-21 |
NZ561743A (en) | 2009-09-25 |
JP2008531518A (ja) | 2008-08-14 |
EA200701615A1 (ru) | 2008-02-28 |
US20090105236A1 (en) | 2009-04-23 |
TW200640465A (en) | 2006-12-01 |
DE102005008921A1 (de) | 2006-08-31 |
AU2006218010B2 (en) | 2013-02-14 |
UY29394A1 (es) | 2006-10-02 |
EP1856070A1 (de) | 2007-11-21 |
UA90504C2 (ru) | 2010-05-11 |
AU2006218010A1 (en) | 2006-08-31 |
WO2006089859A1 (de) | 2006-08-31 |
MX2007010363A (es) | 2007-09-25 |
PL1856070T3 (pl) | 2011-12-30 |
CN101128444A (zh) | 2008-02-20 |
DK1856070T3 (da) | 2011-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073176L (no) | Nye medikamenter for behandling av luftveissykdommer | |
NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
NO20052883L (no) | Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom. | |
NO20061151L (no) | Succinat- og malonatsalt av trans-4-((ir,3s)-6-klor-3-fenylindan-i-yl)-1,2,2-trimetylpiperazin og anvendelsen som et medikament | |
TW200621762A (en) | Novel compounds | |
NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
MY145647A (en) | (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states) | |
MX2008013836A (es) | Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos. | |
TW200615266A (en) | Organic compounds | |
NO20070576L (no) | Nye hydantionderivater for behandling av obstruktive luftveissykdommer. | |
WO2007087548A3 (en) | Chemical compounds | |
TW200626553A (en) | Novel compounds | |
NO20064078L (no) | Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter | |
WO2006096444A3 (en) | Chemical compounds | |
NO20065061L (no) | Benzoksazin for behandling av sykdommer i luftveiene | |
TW200639156A (en) | New compounds | |
CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
ATE453617T1 (de) | Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien | |
CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
NO20043792L (no) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
NO20083790L (no) | Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser | |
NO20090067L (no) | Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer | |
MY139613A (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
MA28930B1 (fr) | Derives pyridiniques d'indolin-2-one , leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |